tert-butylhydroperoxide has been researched along with rosiglitazone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, H; Chen, HL; Hai, CX; Li, WL; Liang, X; Liu, R; Qin, XJ; Wang, X; Zhang, W; Zhang, XD | 1 |
| Delalonde-Delaunay, L; Donello, J; Luhrs, K; Maurier-Mahé, F; McLaughlin, A; Pallares, D; Rodrigues, GA; Schweighoffer, F; Shurland, DL; Throo, E | 1 |
2 other study(ies) available for tert-butylhydroperoxide and rosiglitazone
| Article | Year |
|---|---|
Protective effect of the peroxisome proliferator-activated receptor (PPAR)-γ, ligand rosiglitazone on tert-butyl hydroperoxide-induced QZG cell injury.
Topics: Antioxidants; Cell Culture Techniques; Cell Line; Cell Survival; Data Interpretation, Statistical; Flow Cytometry; Humans; Microscopy, Electron, Transmission; Microscopy, Phase-Contrast; Oxidative Stress; PPAR gamma; Rosiglitazone; tert-Butylhydroperoxide; Thiazolidinediones | 2011 |
Differential effects of PPARgamma ligands on oxidative stress-induced death of retinal pigmented epithelial cells.
Topics: Apoptosis; Blotting, Western; Caspase 3; Cell Line; Cell Survival; Drug Synergism; Gene Silencing; Humans; Ligands; Microarray Analysis; Oxidative Stress; Pioglitazone; PPAR gamma; Reactive Oxygen Species; Retinal Pigment Epithelium; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Rosiglitazone; tert-Butylhydroperoxide; Thiazolidinediones; Transfection | 2011 |